Details about Paul Grootendorst

Access statistics for papers by Paul Grootendorst.

Last updated 2011-04-13. Update your information in the RePEc Author Service.

Short-id: pgr189

Working Papers

2010

1. New Approaches to Rewarding Pharmaceutical Innovation
   Levine's Bibliography, UCLA Department of Economics

2009

2. How should we support pharmaceutical innovation?
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University View citations (3)
3. Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation?
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University

2007

4. A review of instrumental variables estimation in the applied health sciences
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University
5. Effects of 'Authorized-Generics' on Canadian Drug Prices
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University
6. The life expectancy gains from pharmaceutical drugs: a critical appraisal of the literature
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University View citations (1)

2004

7. The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs
   Social and Economic Dimensions of an Aging Population Research Papers, McMaster University View citations (3)

2003

8. National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?
   Quantitative Studies in Economics and Population Research Reports, McMaster University
   Also in Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2003)
   See also Journal Article in Canadian Public Policy (2005)
9. Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs
   IZA Discussion Papers, Institute for the Study of Labor (IZA) View citations (1)
   Also in Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2002)
   Quantitative Studies in Economics and Population Research Reports, McMaster University (2002)

2002

10. Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population
    Social and Economic Dimensions of an Aging Population Research Papers, McMaster University View citations (2)
    Also in Quantitative Studies in Economics and Population Research Reports, McMaster University (2002) View citations (2)
11. The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary
    Quantitative Studies in Economics and Population Research Reports, McMaster University
    Also in Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2002) View citations (1)
12. The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report
    Quantitative Studies in Economics and Population Research Reports, McMaster University
    Also in Social and Economic Dimensions of an Aging Population Research Papers, McMaster University (2002)

2001

13. An Empirical Analysis of Milk Addiction
    Working Papers, Department of Economics, University of Calgary
    See also Journal Article in Journal of Health Economics (2004)
14. International Experience With Pharmaceutical Policy: Common Challenges and Lessons for Canada
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (2)

2000

15. The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada
    Social and Economic Dimensions of an Aging Population Research Papers, McMaster University
    Also in CEPR Discussion Papers, Centre for Economic Policy Research, Research School of Economics, Australian National University (2000)
    Quantitative Studies in Economics and Population Research Reports, McMaster University (2000) View citations (1)
    See also Journal Article in Journal of Health Economics (2002)

1999

16. Beneficiary Cost Sharing Under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (10)
17. Evidence of Construct Validity for Stoke and Arthritis in a Population Health Survey
    Department of Economics Working Papers, McMaster University View citations (2)
18. Health Utilities Index Mark 3: Evidence of Construct Validity for Stroke and Arthritis in a Population Health Survey
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (4)

1998

19. Variance in Pharmacare Coverage Across Canada
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (1)

1996

20. Financial Incentives to Dispense Low-Cost Drugs: A Case Study of British Columbia Pharmacare
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (1)

1995

21. On Becoming 65 in Ontario: Effects of Provincial Drug Plan Eligibility on Utilization of Prescription Medicines
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (2)

1994

22. Does It Matter Whom and How You Ask? Inter and Intra-rater Agreement in the Ontario Health Survey
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada View citations (6)

1993

23. Results of an Investigation into the Integrity of the Ontario Health Survey
    Centre for Health Economics and Policy Analysis Working Paper Series, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada

Journal Articles

2011

1. The cost of drug development: A systematic review
   Health Policy, 2011, 100, (1), 4-17 View citations (1)

2007

2. The effects of coxib formulary restrictions on analgesic use and cost: Regional evidence from Canada
   Health Policy, 2007, 84, (1), 1-13

2006

3. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia
   Health Economics, 2006, 15, (7), 735-742 View citations (4)

2005

4. Distributional effects of `general population' prescription drug programs in Canada
   Canadian Journal of Economics, 2005, 38, (1), 128-148 View citations (1)
5. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada
   Health Economics, 2005, 14, (9), 909-923 View citations (11)
6. National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?
   Canadian Public Policy, 2005, 31, (4), 341-358
   See also Working Paper (2003)

2004

7. An empirical analysis of milk addiction
   Journal of Health Economics, 2004, 23, (6), 1117-1133 View citations (17)
   See also Working Paper (2001)

2002

8. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada
   Journal of Health Economics, 2002, 21, (5), 805-826 View citations (8)
   See also Working Paper (2000)

2001

9. On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective
   Health Policy, 2001, 55, (2), 97-109 View citations (1)

1997

10. Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator
    Health Economics, 1997, 6, (4), 365-382 View citations (8)